Clinical Trial Update: A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer [Phase 3]

View source ↗

Summary

A Phase III study evaluating bevacizumab and paclitaxel with atezolizumab for locally advanced unresectable or metastatic hormone receptor-positive, HER2-negati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Japanese Foundation for Cancer Research | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED